PPARG and cancer: Numerous other examples of differentialeffects among PPARγ agonists exist (e.g., [113–116]), but it is worth stressingthat n-3 PUFAs inhibit the metabolism of n-6 PUFAs to products that promote thegrowth of cancer cells such as PGE2, 5-HETE, and leukotriene B4[33–35, 45, 113].